Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Mar 31, 2025 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 8.01%21.15B | 0.22%19.58B | 9.25%5.79B | 2.54%4.57B | -6.61%5.2B | -4.55%4.03B | 19.54B | 1.58%5.3B | -0.37%4.46B | 16.17%5.56B |
| Cost of revenue | 11.26%5.36B | 2.46%4.82B | 16.93%1.43B | 7.36%1.19B | -9.71%1.23B | -3.93%972.33M | 4.7B | -3.72%1.22B | 6.02%1.11B | 17.29%1.36B |
| Gross profit | 6.95%15.79B | -0.49%14.76B | 6.95%4.36B | 0.95%3.38B | -5.61%3.96B | -4.74%3.06B | 14.84B | 3.29%4.08B | -2.32%3.35B | 15.81%4.2B |
| Operating expense | 8.32%15.39B | 1.27%14.21B | -5.90%3.43B | 9.49%3.63B | -1.85%3.51B | 4.14%3.64B | 14.03B | 4.07%3.64B | -1.75%3.32B | 4.32%3.58B |
| Operating profit | -28.44%395.2M | -31.31%552.27M | 115.25%930.15M | -898.17%-251.88M | -27.15%454.13M | -104.89%-580.13M | 803.96M | -2.90%432.14M | -39.11%31.56M | 214.39%623.41M |
| Net non-operating interest income (expenses) | 68.25%189.84M | 5.32%112.83M | -16.85%24.74M | 1.34%30.31M | -12.15%27.26M | 85.55%30.53M | 107.13M | 484.59%29.75M | 972.74%29.91M | 2,080.18%31.02M |
| Non-operating interest income | 169.38%371.63M | 28.10%137.96M | 65.39%49.43M | 1.35%30.46M | -12.08%27.4M | 84.84%30.67M | --107.7M | 471.82%29.89M | 893.68%30.05M | 1,580.16%31.17M |
| Non-operating interest expense | 623.47%181.79M | 4,363.23%25.13M | 17,666.19%24.7M | 3.55%146K | 2.10%146K | 0.71%141K | --563K | 0.72%139K | -40.25%141K | -66.90%143K |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | -408.83%-40.47M | -16.92%-7.95M | 21.79%-8.87M | -90.70%408K | 113.01%728K | -103.90%-224K | -6.8M | 94.77%-11.34M | 484.15%4.39M | -280.32%-5.6M |
| Less:Other special charges | 275.01%14.74M | 144.16%3.93M | 255.43%5.08M | 90.85%-408K | -120.59%-991K | 104.19%251K | ---8.9M | -21,680.00%-3.27M | -62.29%-4.46M | 211.18%4.81M |
| Less:Write off | 539.55%25.73M | -74.38%4.02M | -74.07%3.79M | --0 | -66.41%263K | -111.02%-27K | --15.7M | -93.27%14.6M | -96.44%71K | -36.13%783K |
| Other non-operating income (expenses) | 338.01%113.95M | 14.81%-47.88M | -1.43%-99.96M | 0.15%9.88M | -19.55%11.66M | 69.77%30.55M | -56.2M | -25.29%-98.55M | 135.83%9.86M | -87.12%14.49M |
| Income before tax | 8.08%658.52M | -28.16%609.27M | 140.36%846.06M | -379.05%-211.29M | -25.56%493.77M | -113.73%-519.28M | 848.09M | 127.78%352M | 171.87%75.72M | 110.34%663.33M |
| Income tax | 5.30%404.36M | 14.99%384M | 101.46%398.29M | -265.49%-43.85M | -13.16%193.03M | -45.27%-163.47M | 333.94M | 263.64%197.7M | -26.88%26.5M | 78.53%222.28M |
| Net income | 12.82%254.16M | -56.18%225.27M | 190.20%447.77M | -440.17%-167.44M | -31.81%300.74M | -172.80%-355.8M | 514.15M | -43.96%154.3M | 687.08%49.22M | 131.10%441.05M |
| Net income continuous operations | 12.82%254.16M | -56.18%225.27M | 190.20%447.78M | -440.18%-167.44M | -31.81%300.74M | -172.80%-355.8M | --514.15M | -43.96%154.3M | 687.14%49.22M | 131.10%441.05M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 12.82%254.16M | -56.18%225.27M | 190.20%447.77M | -440.17%-167.44M | -31.81%300.74M | -172.80%-355.8M | 514.15M | -43.96%154.3M | 687.08%49.22M | 131.10%441.05M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 12.82%254.16M | -56.18%225.27M | 190.20%447.77M | -440.17%-167.44M | -31.81%300.74M | -172.80%-355.8M | 514.15M | -43.96%154.3M | 687.08%49.22M | 131.10%441.05M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 13.06%2.51 | -56.30%2.22 | 188.89%4.42 | -445.83%-1.66 | -31.88%2.97 | -172.09%-3.51 | 5.08 | -43.75%1.53 | 700.00%0.48 | 131.91%4.36 |
| Diluted earnings per share | 13.06%2.51 | -56.30%2.22 | 190.16%4.42 | -445.83%-1.66 | -31.81%2.9689 | -172.09%-3.51 | 5.08 | -43.96%1.5233 | 679.93%0.48 | 131.60%4.3541 |
| Dividend per share | 0.00%1 | 0.00%1 | 0.00%1 | 0 | 0 | 0 | 1 | 0.00%1 | 0 | 0 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |